PODD (Partnership Opportunities in Drug Delivery): Pharma, biotech and drug delivery industries will gather at the 15th annual PODD event to assess delivery needs, explore partnership opportunities, and stay at the forefront of innovative drug delivery technologies. This includes small molecules, biologics, combination products, connected devices, cell and gene delivery and more.

Come and visit our booth #705.

‘One device, 10-year life. A new era in drug delivery’ – come and hear our talk on implantable drug delivery with Elizabeth Proos from Daré and Ashley Hawson from Cambridge Consultants on Day 2, 2:30 – 2:45.

‘Ensuring sustainability throughout drug and device development’ – come and hear Charlie Dean speak on the panel hosted by Ulrich Brueggemann at Takeda, Day 2, 4:05.

チャーリー・ディーン

メディカルテクノロジー事業本部　 サスティナブルメディカルテクノロジーG　グループリーダー | プロフィールを見る

チャーリーはメディカルテクノロジー事業本部のサステナブルメディカルテクノロジーグループのリーダーであり、医療機器開発における機械設計と解析手法に精通しています。LCA（ライフサイクルアセスメント）の専門家として、医療製品の評価と設計を主導し、環境負荷の低減やサーキュラーエコノミーの推進に取り組んでいます。

Philip Canner

VP Drug Delivery | プロフィールを見る

With over eighteen years' experience in medical device leadership, engineering, and management consultancy, Phil has worked on the development of an extensive range of medical technologies, with a particular focus on drug delivery.

アシュレイ　ホーソン

SVP, Innovation & Operations | プロフィールを見る

Ashley leads the Healthcare and North America operations, overseeing a multidisciplinary team of more than 100 engineers, scientists, and designers who are pioneering advances in Class II and III medical devices, photonics, human–machine understanding, and regulated medical AI.